The effect of HBV replication inhibition suggest that GRP78 up-regulation is of therapeutic potential for chronic HBV infection, but the rest effects on promoting virion secretion and HCC invasion argue against the above potential. Here, HSPA5 is linked to hepatocellular carcinoma.